MATEON THERAPEUTICS INC·4

Jun 22, 4:15 PM ET

Reynolds Donald Rogers 4

4 · MATEON THERAPEUTICS INC · Filed Jun 22, 2018

Insider Transaction Report

Form 4
Period: 2018-06-20
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1][F2]
    2018-06-20+258,171258,171 total
    Exercise: $0.22Exp: 2024-06-20Common Stock (258,171 underlying)
Footnotes (2)
  • [F1]Mr. Reynolds was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per shares (the "Stock Options"), in connection with his service as a member of the Board of Directors pursuant to the Amended and Restated Mateon Therapeutics, Inc. 2015 Equity Incentive Plan and the Amended and Restated Non-Employee Director Compensation Policy.
  • [F2]The Stock Options will vest in full on June 20, 2019, subject to Mr. Reynolds' continued service on the Board of Directors as of such date.
Signature
Megan N. Gates, attorney-in-fact|2018-06-22

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION